IBRX vs. GME
Compare and contrast key facts about ImmunityBio, Inc. (IBRX) and GameStop Corp. (GME).
Performance
IBRX vs. GME - Performance Comparison
Loading graphics...
IBRX vs. GME - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
IBRX ImmunityBio, Inc. | 260.61% | -22.66% | -49.00% | -0.99% | -16.61% | -54.39% | 251.72% | 226.72% | -74.16% | -21.50% |
GME GameStop Corp. | 13.35% | -35.93% | 78.78% | -5.04% | -50.24% | 687.63% | 209.87% | -50.19% | -22.17% | -23.66% |
Fundamentals
IBRX:
$7.07B
GME:
$12.50B
IBRX:
-$0.37
GME:
$0.77
IBRX:
59.34
GME:
3.43
IBRX:
$113.29M
GME:
$3.63B
IBRX:
$112.54M
GME:
$1.20B
IBRX:
-$257.20M
GME:
$255.60M
Returns By Period
In the year-to-date period, IBRX achieves a 260.61% return, which is significantly higher than GME's 13.35% return. Over the past 10 years, IBRX has underperformed GME with an annualized return of -1.88%, while GME has yielded a comparatively higher 14.04% annualized return.
IBRX
- 1D
- -6.91%
- 1M
- -31.61%
- YTD
- 260.61%
- 6M
- 187.90%
- 1Y
- 141.22%
- 3Y*
- 57.72%
- 5Y*
- -20.44%
- 10Y*
- -1.88%
GME
- 1D
- -1.22%
- 1M
- -5.95%
- YTD
- 13.35%
- 6M
- -17.80%
- 1Y
- 0.66%
- 3Y*
- -0.38%
- 5Y*
- -13.81%
- 10Y*
- 14.04%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
IBRX vs. GME — Risk / Return Rank
IBRX
GME
IBRX vs. GME - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for ImmunityBio, Inc. (IBRX) and GameStop Corp. (GME). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| IBRX | GME | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 1.31 | 0.01 | +1.29 |
Sortino ratioReturn per unit of downside risk | 2.43 | 0.35 | +2.08 |
Omega ratioGain probability vs. loss probability | 1.29 | 1.05 | +0.24 |
Calmar ratioReturn relative to maximum drawdown | 3.23 | 0.05 | +3.19 |
Martin ratioReturn relative to average drawdown | 5.28 | 0.06 | +5.22 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| IBRX | GME | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.31 | 0.01 | +1.29 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.18 | -0.14 | -0.04 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | -0.02 | 0.12 | -0.14 |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.12 | 0.14 | -0.26 |
Correlation
The correlation between IBRX and GME is 0.23, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Dividends
IBRX vs. GME - Dividend Comparison
Neither IBRX nor GME has paid dividends to shareholders.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
IBRX ImmunityBio, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
GME GameStop Corp. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 6.25% | 12.04% | 8.47% | 5.86% | 5.14% |
Drawdowns
IBRX vs. GME - Drawdown Comparison
The maximum IBRX drawdown since its inception was -97.14%, roughly equal to the maximum GME drawdown of -93.43%. Use the drawdown chart below to compare losses from any high point for IBRX and GME.
Loading graphics...
Drawdown Indicators
| IBRX | GME | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -97.14% | -93.43% | -3.71% |
Max Drawdown (1Y)Largest decline over 1 year | -42.44% | -43.04% | +0.60% |
Max Drawdown (5Y)Largest decline over 5 years | -94.40% | -86.77% | -7.63% |
Max Drawdown (10Y)Largest decline over 10 years | -97.03% | -89.25% | -7.78% |
Current DrawdownCurrent decline from peak | -83.10% | -73.80% | -9.30% |
Average DrawdownAverage peak-to-trough decline | -83.94% | -49.09% | -34.85% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 25.97% | 30.80% | -4.83% |
Volatility
IBRX vs. GME - Volatility Comparison
ImmunityBio, Inc. (IBRX) has a higher volatility of 38.62% compared to GameStop Corp. (GME) at 8.29%. This indicates that IBRX's price experiences larger fluctuations and is considered to be riskier than GME based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| IBRX | GME | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 38.62% | 8.29% | +30.33% |
Volatility (6M)Calculated over the trailing 6-month period | 88.04% | 25.13% | +62.91% |
Volatility (1Y)Calculated over the trailing 1-year period | 108.71% | 47.21% | +61.50% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 113.62% | 98.27% | +15.35% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 111.61% | 117.76% | -6.15% |
Financials
IBRX vs. GME - Financials Comparison
This section allows you to compare key financial metrics between ImmunityBio, Inc. and GameStop Corp.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities